1. A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. Issue 25 (9th June 2015) Authors: Tameris, M.; Hokey, D.A.; Nduba, V.; Sacarlal, J.; Laher, F.; Kiringa, G.; Gondo, K.; Lazarus, E.M.; Gray, G.E.; Nachman, S.; Mahomed, H.; Downing, K.; Abel, B.; Scriba, T.J.; McClain, J.B.; Pau, M.G.; Hendriks, J.; Dheenadhayalan, V.; Ishmukhamedov, S.; Luabeya, A.K.K. Journal: Vaccine Issue: Volume 33:Issue 25(2015) Page Start: 2944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗